http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2178298-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e58b17ef730ad6201fc70d095b88e907
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3368235b8b9d7db90aeeb7776cefd27c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4166
filingDate 2000-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1cce1be8be170e620c1eccc5b8738b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c98c1ecaa4c8f8501fbce9a895bc17e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88d6eece6c95873cf11784d6a6778523
publicationDate 2002-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2178298-C1
titleOfInvention Method of therapy in patients with pharmacotherapy- resistant epilepsy forms
abstract FIELD: medicine, psychotherapy, neurology. SUBSTANCE: antiepileptic preparations are twice or thrice injected daily with a gradual increase of daily doses. When side effects appear during 2-3 wk corresponding to 3-5 half-life periods of a preparation, a daily dose and intake frequency of antiepileptic preparations are kept to obtain a stable 25-50% decrease of blood free fraction concentration of a preparation. Then intake frequency has a two- fold increase, not less. At achieving stable values of blood free fraction concentration of a preparation in case of insufficient therapeutic effect a daily dose should be increased to reach a tolerance one. EFFECT: higher efficiency of therapy to remove undesirable side effects. 2 cl, 1 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9763954-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364247-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10695354-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10702536-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10675287-B2
priorityDate 2000-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID125422
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484141
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415825511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501183

Total number of triples: 38.